MX2011008138A - Metodos para diagnosticar falla de articulacion inminente. - Google Patents

Metodos para diagnosticar falla de articulacion inminente.

Info

Publication number
MX2011008138A
MX2011008138A MX2011008138A MX2011008138A MX2011008138A MX 2011008138 A MX2011008138 A MX 2011008138A MX 2011008138 A MX2011008138 A MX 2011008138A MX 2011008138 A MX2011008138 A MX 2011008138A MX 2011008138 A MX2011008138 A MX 2011008138A
Authority
MX
Mexico
Prior art keywords
joint failure
methods
impending joint
diagnosing
diagnosing impending
Prior art date
Application number
MX2011008138A
Other languages
English (en)
Inventor
Wendell Ray Guffey
Dennis Lawler
Selena E Richards
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of MX2011008138A publication Critical patent/MX2011008138A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N24/00—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects
    • G01N24/08—Investigating or analyzing materials by the use of nuclear magnetic resonance, electron paramagnetic resonance or other spin effects by using nuclear magnetic resonance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La invención proporciona métodos para diagnosticar el fallo conjunto inminente en un animal midiendo la concentración de fenilalanina en un fluido corporal; midiendo la concentración de uno o más de tirosina, alanina, valina y glutamina en el fluido corporal; determinando el radio de la fenilalanina para uno o más de tirosina, alanina, valina y glutamina; y diagnosticar el fallo conjunto inminente comparando del radio a radios predicativo del fallo conjunto inminente.
MX2011008138A 2009-02-02 2010-01-29 Metodos para diagnosticar falla de articulacion inminente. MX2011008138A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20664009P 2009-02-02 2009-02-02
PCT/US2010/000270 WO2010087991A2 (en) 2009-02-02 2010-01-29 Methods for diagnosing impending joint failure

Publications (1)

Publication Number Publication Date
MX2011008138A true MX2011008138A (es) 2012-05-08

Family

ID=42396264

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011008138A MX2011008138A (es) 2009-02-02 2010-01-29 Metodos para diagnosticar falla de articulacion inminente.

Country Status (11)

Country Link
US (1) US20130078732A1 (es)
EP (1) EP2391889A4 (es)
JP (1) JP2012516995A (es)
CN (1) CN102439442A (es)
AU (1) AU2010208656A1 (es)
BR (1) BRPI1007896A2 (es)
CA (1) CA2750608A1 (es)
MX (1) MX2011008138A (es)
RU (1) RU2011136275A (es)
WO (1) WO2010087991A2 (es)
ZA (1) ZA201106421B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11181594B2 (en) * 2014-11-13 2021-11-23 Brigham And Women's Hospital, Inc. System and method for locally correlated spectroscopy for assessing medical discorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005274B1 (en) 1999-09-15 2006-02-28 Migenix Corp. Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass
US7840247B2 (en) * 2002-09-16 2010-11-23 Imatx, Inc. Methods of predicting musculoskeletal disease
NL1021753C2 (nl) * 2002-10-25 2004-04-27 Tno Detectie van osteoarthritis.
CA2522290A1 (en) * 2003-04-15 2004-10-28 Metgen, Inc. Medical device for monitoring blood phenylalanine levels
WO2006007664A1 (en) * 2004-07-22 2006-01-26 Genomics Research Partners Pty Ltd Agents and methods for diagnosing osteoarthritis
US7702469B2 (en) * 2006-04-10 2010-04-20 Academisch Ziekenhuis Leiden H.O.D.N. Lumc Systems and methods for predicting an individual's risk of developing rheumatoid arthritis
WO2008036239A2 (en) * 2006-09-19 2008-03-27 Wyeth Use of lxr agonists for the treatment of osteoarthritis
WO2008049225A1 (en) 2006-10-25 2008-05-02 Chu Sainte Justine Methods for diagnosing osteoarthritis

Also Published As

Publication number Publication date
AU2010208656A1 (en) 2011-08-18
ZA201106421B (en) 2015-11-25
BRPI1007896A2 (pt) 2016-02-16
JP2012516995A (ja) 2012-07-26
RU2011136275A (ru) 2013-03-10
WO2010087991A3 (en) 2011-12-22
CN102439442A (zh) 2012-05-02
EP2391889A2 (en) 2011-12-07
CA2750608A1 (en) 2010-08-05
EP2391889A4 (en) 2012-11-21
WO2010087991A2 (en) 2010-08-05
US20130078732A1 (en) 2013-03-28

Similar Documents

Publication Publication Date Title
ATE548050T1 (de) Diagnoseverfahren
CY1120434T1 (el) Πρωτεϊνες προσδεσης il-1
WO2011142924A3 (en) A method and system for determining levels of gases
CR20120371A (es) Antagonistas de pcsk9
MX354890B (es) Medicion de propiedades quimicas de un fluido de muestra en sistemas de dialisis.
TR201903507T4 (tr) Boru hatlarında izleme nesneleri.
CR8740A (es) Cartucho mecanico con caracteristicas de control fluido en tira de prueba, para utilizar en un medidor de analitos fluidos
WO2010135574A3 (en) Systems and methods for determining the percentage of glycated hemoglobin
ATE493290T1 (de) Alcotestgerät
BRPI1014652A2 (pt) sensor eletroquímico amperométrico, método para fabricar o mesmo, sonda amperométrica de medição do teor de uma substância de oxirredução dissolvida em um líquido e uso de um sensor.
NI200900081U (es) Anticuerpos agonistas de trkb y sus usos.
EA201171178A1 (ru) Устройство и способ для определения и количественного анализа аналитов, в частности, микотоксинов
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
EA201391627A1 (ru) Анализ на наличие лизилоксидазоподобных белков 2 и способы его применения
GB201014028D0 (en) In-situ reagent
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ594772A (en) Diagnosis and prognosis of renal injury and renal failure using vitamin k dependent protein c
EP1825261A4 (en) DIAGNOSIS OF SUFFERING IN CONNECTION WITH REDUCED ARGININ BIOVERABILITY
FR2910109B3 (fr) Raccord rapide de canalisation.
ES2572368T3 (es) Tratamiento de la artrosis
MX2011008138A (es) Metodos para diagnosticar falla de articulacion inminente.
WO2010032991A3 (ko) 엔테로바이러스 검출용 프라이머, 탐침 및 이를 이용한 엔테로바이러스 검출방법
RU2009110124A (ru) Антигельминтное средство для лечения кабанов
TW200728471A (en) Probe set, kit and method for sex determination of bovine or ovine cells
WO2012075312A3 (en) Compositions and methods for neisseria gonorrhoeae diagnostic testing

Legal Events

Date Code Title Description
FA Abandonment or withdrawal